Oxidative stress and mitochondrial dynamics malfunction are linked in P elizaeus‐M erzbacher disease
M Ruiz, M Bégou, N Launay, P Ranea‐Robles… - Brain …, 2018 - Wiley Online Library
Pelizaeus‐Merzbacher disease (PMD) is a fatal hypomyelinating disorder characterized by
early impairment of motor development, nystagmus, choreoathetotic movements, ataxia and …
early impairment of motor development, nystagmus, choreoathetotic movements, ataxia and …
High‐dose biotin restores redox balance, energy and lipid homeostasis, and axonal health in a model of adrenoleukodystrophy
Biotin is an essential cofactor for carboxylases that regulates the energy metabolism.
Recently, high‐dose pharmaceutical‐grade biotin (MD1003) was shown to improve clinical …
Recently, high‐dose pharmaceutical‐grade biotin (MD1003) was shown to improve clinical …
[HTML][HTML] Pioglitazone treatment increases the cellular acid-labile and protein-bound sulfane sulfur fractions
MZ Islam, RE Shackelford - Biochemical and Biophysical Research …, 2023 - Elsevier
Background Iron-sulfur clusters play a central role in cellular function and are regulated by
the ATM protein. Iron-sulfur clusters are part of the cellular sulfide pool, which functions to …
the ATM protein. Iron-sulfur clusters are part of the cellular sulfide pool, which functions to …
Activation of sirtuin 1 as therapy for the peroxisomal disease adrenoleukodystrophy
Oxidative stress and mitochondrial failure are prominent factors in the axonal degeneration
process. In this study, we demonstrate that sirtuin 1 (SIRT1), a key regulator of the …
process. In this study, we demonstrate that sirtuin 1 (SIRT1), a key regulator of the …
The role of oxidative stress and inflammation in X-link adrenoleukodystrophy
J Yu, T Chen, X Guo, MI Zafar, H Li, Z Wang… - Frontiers in …, 2022 - frontiersin.org
X-linked adrenoleukodystrophy (X-ALD) is an inherited disease caused by a mutation in the
ABCD1 gene encoding a peroxisomal transmembrane protein. It is characterized by the …
ABCD1 gene encoding a peroxisomal transmembrane protein. It is characterized by the …
Drug discovery for X‐linked adrenoleukodystrophy: An unbiased screen for compounds that lower very long‐chain fatty acids
AB Moser, Y Liu, X Shi, U Schrifl… - Journal of cellular …, 2021 - Wiley Online Library
X‐linked adrenoleukodystrophy (XALD) is a genetic neurologic disorder with multiple
phenotypic presentations and limited therapeutic options. The childhood cerebral phenotype …
phenotypic presentations and limited therapeutic options. The childhood cerebral phenotype …
Pioglitazone ameliorates methotrexate-induced renal endothelial dysfunction via amending detrimental changes in some antioxidant parameters, systemic cytokines …
Methotrexate (MTX) is widely used in treatment of cancers and autoimmune diseases.
However, nephrotoxicity is one of its most important side effects. The peroxisome proliferator …
However, nephrotoxicity is one of its most important side effects. The peroxisome proliferator …
Paradoxical inhibition of glycolysis by pioglitazone opposes the mitochondriopathy caused by AIF deficiency
Mice with the hypomorphic AIF-Harlequin mutation exhibit a highly heterogeneous
mitochondriopathy that mostly affects respiratory chain complex I, causing a cerebral …
mitochondriopathy that mostly affects respiratory chain complex I, causing a cerebral …
Brain lipotoxicity of phytanic acid and very long-chain fatty acids. harmful cellular/mitochondrial activities in Refsum disease and X-linked adrenoleukodystrophy
P Schonfeld, G Reiser - Aging and disease, 2016 - go.gale.com
It is increasingly understood that in the aging brain, especially in the case of patients
suffering from neurodegenerative diseases, some fatty acids at pathologically high …
suffering from neurodegenerative diseases, some fatty acids at pathologically high …
Novel therapeutic targets and drug candidates for modifying disease progression in adrenoleukodystrophy
A Pujol - Advanced Therapies in Pediatric Endocrinology and …, 2016 - karger.com
X-linked adrenoleukodystrophy (X-ALD) is the most frequent inherited monogenic
demyelinating disease. It is often lethal and currently lacks a satisfactory therapy. The …
demyelinating disease. It is often lethal and currently lacks a satisfactory therapy. The …